Clinical Trial Update: A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD [Phase 2, Phase 3]

View source ↗

Summary

This entry provides the status of a Phase 2/Phase 3 trial evaluating Octreotide Subcutaneous Depot for polycystic liver disease, currently ACTIVE_NOT_RECRUITING…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Liver Disease

Drugs mentioned

• Octreotide Subcutaneous Depot (octreotide)

Snippet

Sponsor: Camurus AB | Conditions: Polycystic Liver Disease | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING